Navigation Links
Genes that control cell death fingered in age-related hearing loss
Date:10/16/2008

familiar process to scientists who know that it also happens as part of the course of many diseases. For instance, after a stroke, many brain cells perceive a threat low oxygen and "jump ship," killing themselves and dramatically worsening the effects of the stroke.

The new research is the first demonstration that such activity also occurs in the aging inner ear. The work offers a potential new target as scientists work to find ways to stop age-related hearing loss, such as a drug that would stop cells from committing cell suicide as they age.

"The goal, of course, is to prevent and even reverse age-related hearing loss, which is the third most common chronic medical condition among the elderly," said Frisina, who also has appointments in the departments of Biomedical Engineering and Neurobiology and Anatomy. "Right now, there is nothing we can do to treat it or reverse it, so prevention is the focus."

Frisina advises avoiding exposure to loud noise wherever possible, and wearing ear protection when working with power tools or hunting, for example. Since many medications can damage hearing, patients should speak at length with their doctors about side effects before going on medications, particularly antibiotics, hormone therapy, and drugs that fight cancer. Since conditions like diabetes can also damage hearing, heed the timeless advice to eat right and exercise.


'/>"/>

Contact: Tom Rickey
tom_rickey@urmc.rochester.edu
585-275-7954
University of Rochester Medical Center
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related biology news :

1. Researchers continue to find genes for type 1 diabetes
2. Brainy genes, not brawn, key to success on mussel beach
3. New tool probes function of rice genes
4. Fishy future written in the genes
5. Scientist plans to test for blood pressure genes affected by age
6. NIHs Genes, Environment and Health Initiative adds 6 studies
7. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
8. £2 million study to reveal workings of dementia genes
9. Scientists identify the genes that cause blindness produced by corneal edema
10. Biologists identify genes controlling rhythmic plant growth
11. Biological clock genes control plant growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2009)... LA JOLLA, CADecember 10, 2009Researchers at The Scripps ... how a single protein from an ancient family ... in the body. In addition to providing guidance ... research supplies a theoretical underpinning for the protein,s ... macular degeneration. , The research was published in ...
(Date:12/11/2009)... green plants photosynthesize, absorb carbon dioxide and produce ... that photosynthesis has had on Earth. One of ... evolution of photosynthesis is Jeffrey Touchman, assistant professor ... , Oxygen, one of the by-products of photosynthesis ... (including algae and higher plants), transformed the Precambrian ...
(Date:12/11/2009)... professor of anthropology at the University of Arizona, has ... understand how violence shapes the health of those eking ... and her colleagues, research," Documenting the health consequences of ... A conceptual framework," is currently published in a special ... collaboration with the British medical journal the Lancet ...
Breaking Biology News(10 mins):Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3'Extreme' genes shed light on origins of photosynthesis 2'Extreme' genes shed light on origins of photosynthesis 3UA-led study grapples with health effects of low-intensity warfare 2Changing Paradigms in Hereditary Angioedema 3A Pathophysiology Diagnosis and Treatment 50301 1Changing Paradigms in Hereditary Angioedema 3A Pathophysiology Diagnosis and Treatment 50301 2Alpharmas Reach Teach Learn Initiative Targets Youth and Consumer Awareness 50298 1Alpharmas Reach Teach Learn Initiative Targets Youth and Consumer Awareness 50298 2Risk of cancer 50297 1
... University Hospital of Magdeburg (Germany) have discovered that ... oxidative stress followed by the activation of the ... gene expression in atrial tissue. Their study will ... Biology and Medicine. Multiple tachycardia-associated factors appear to ...
... of Chicago scientists has shown how two proteins locate ... protein detects and repairs damage in malignant cells that ... In a paper published in the April 24 issue ... of designing a molecule that could interfere with the ...
... available in German . , , Professor Wolfgang ... a physicist from Warsaw, have been selected to receive ... Research Foundation) and the Foundation for Polish Science (FNP) ... is in recognition of their many years of fruitful ...
Other Biology News:Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia 2Researchers reveal structure of protein that repairs damage to cancer cells 2Researchers reveal structure of protein that repairs damage to cancer cells 3Outstanding German-Polish scientific cooperation 2Outstanding German-Polish scientific cooperation 3
(Date:12/11/2009)... (Nasdaq: DNDN ) announced today that the ... exercised in full their option to purchase an ... public offering price of $24.75 per share. ... of the offering to an aggregate of 17,250,000 ... receive net proceeds from the offering of approximately ...
(Date:12/11/2009)... -- Ambit Biosciences Corporation announced today the enrollment and ... Cancer Center of the first patient in the ACE ... fficacy) Phase 2 pivotal trial in patients with ... is a novel, orally available, potent and highly selective ... tyrosine kinase-3 (FLT3) inhibitor. The ACE study is ...
(Date:12/11/2009)... - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ONCY ) ... of Dr. Alan Warrander to the role of ... ,, "Dr. Warrander will be responsible for the ... said Dr. Brad Thompson, President and CEO of ... of a Phase 3 trial examining REOLYSIN in ...
(Date:12/10/2009)... 10 Endologix, Inc. (Nasdaq: ELGX ... disorders, announced today that Dan Lemaitre, former President ... Board of Directors effective December 11, 2009. ... non-independent directors. ,, Franklin D. Brown, Chairman of ... Dan Lemaitre to the Endologix Board of Directors. ...
Breaking Biology Technology:Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3Endologix Appoints Dan Lemaitre to its Board of Directors 2
... Jan. 2 Onyx,Pharmaceuticals, Inc. (Nasdaq: ONXX ... JPMorgan Healthcare Conference on Monday, January 7, at ... live webcast of the,presentation at:, http://www.metameetings.com/webcasts/jpmorgan/healthcare08 ... on 15 minutes early in order to,register and ...
... Cephalon, Inc. (Nasdaq:,CEPH) today announced that it ... U.S. Food and Drug Administration (FDA) requesting approval ... of patients,with indolent B-cell non-Hodgkin,s lymphoma (NHL) who ... a rituximab-containing,regimen. According to the National Cancer Institute, ...
... Dec. 28 Beckman Coulter,Inc. (NYSE: ... marketer of,products that simplify, automate, and innovate ... Beckman Coulter,s president and chief,executive officer, will ... January 8, 2008, at 6:00 p.m. (ET)., ...
Other Biology Technology:Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkin's Lymphoma 2Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkin's Lymphoma 3Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkin's Lymphoma 4
Fingerprinting II Informatix cluster analysis is an optional module that adds dendrogram and phylogenetic tree construction, cluster and group significance, and congruence of techniques functions to ...
... Fingerprinting II Informatix ... an optional module ... component analysis, multidimensional ... and MANOVA, and ...
... PrecisION Ion Channel Cell Lines ,High Quality, ... channels are well known for having a ... and consequently have a key function in ... modulate ion channels have been investigated in ...
... marker mix was designed specifically to aid the ... a complement of seven reduced and denatured proteins ... who use markers to assess 2-D system performance ... proteins undergoing 2-D separation and analysis. , ...
Biology Products: